ESG rises: The role of B-schools in the way ahead
Even until a few years ago, it seemed like a far-fetched, futuristic idea to speak about careers or mainstream investment options...
Stay updated with breaking news from Rd Research. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Even until a few years ago, it seemed like a far-fetched, futuristic idea to speak about careers or mainstream investment options...
Pharmaceutical companies that made billions from the pandemic over the past two years selling vaccines and treatments are now up against a steep Covid cliff and investor pressure to spend their windfalls wisely.
Pharmaceutical companies that made billions from the pandemic over the past 2 years selling vaccines and treatments are now up against a steep COVID cliff and investor pressure to spend their windfalls wisely.
Pharmaceutical companies that made billions from the pandemic over the past two years selling vaccines and treatments are now up against a steep COVID cliff and investor pressure to spend their
By Michael Erman and Patrick Wingrove